Perhaps you should do a thorough review of all the results of TLT's research to date, the groundwork completed toward regulatory approval of trials and determine if it is a suitable speculation for you. For at least the past several months all TLT has said is, human trials in 2015, I was not surprised to see 4th qrtr , I had expected that.
Yes, I dislike over promise and under deliver, that has been the case, in the past, it has become less so in recent months and their progress has been dead steady, meeting their stated goals.
BCT I have put on my list, it is clearly interesting.
TLT, I find more interesting, it is a very novel approach to cancer and their PDT technology has other possible uses as well. They have demonstrated their technology can; detect and identify cancer cells, destroys cancer cells, through apoptosis, and it can induce a vaccine like immune system response. All this in a non toxic, non invasive,
procedure that is localized and does not damage healthy tissue. That is why I am speculating on it and current selling pressure has absolutely no relationship to the fundamentals, so I am not concerned by it, as I have said , I believe it is an opportunity. Cancer detection, cancer destruction, cancer vaccination all in one. Too much promise not to hold this going in to first human trials, primarily designed to prove acceptable safety profile that can only by default also provide efficacy results. |
